Jaka jest cena za SpectraScience, Inc. (SCIE)

Cena za SpectraScience, Inc. (SCIE) wynosi $0.000001

Jaka jest kapitalizacja rynkowa dla SpectraScience, Inc. (SCIE)

Kapitalizacja rynkowa dla SpectraScience, Inc. (SCIE) wynosi $4.92K

SpectraScience, Inc. (SCIE) Stopa Dywidendy

SpectraScience, Inc. specializes in creating and distributing an advanced technological platform designed for the immediate classification of tissue as normal, pre-cancerous, or cancerous, thereby bypassing the requirement for invasive physical biopsies. This innovative approach is accessible in the United States, Europe, and other global regions. The company's product line includes the WavSTAT3 optical biopsy system, which assesses colon tissue for normal, pre-cancerous, or cancerous conditions without surgical removal. Another key offering is the WavSTAT4 optical biopsy system, a diagnostic tool for the colon that employs UV laser light to optically scan and analyze tissue, enabling physicians to make instant diagnoses during endoscopic cancer screenings. Additionally, SpectraScience provides related accessories such as mobile consoles and disposable forceps. The company is also actively developing an application for esophageal diagnostics, focused on identifying pre-cancerous and cancerous tissue formations. Founded in 1983, the company operated as GV Medical, Inc. until it adopted the name SpectraScience, Inc. in October 1992, and is headquartered in San Diego, California.

Rok	Stopa dywidendy	Zmień
Za mało danych dla podanych dat.

Rok

Stopa dywidendy

Zmień

Za mało danych dla podanych dat.

Firma	Stopa dywidendy	Kraj
STERIS plc STE.US	1.10%	IE
Shanghai United Imaging Healthcare Co., Ltd. 688271.SS	0.00%	CN
Ypsomed Holding AG YPSN.SW	0.00%	CH
Medacta Group S.A. MOVE.SW	0.00%	CH
Jafron Biomedical Co.,Ltd. 300529.SZ	0.00%	CN

Firma

Stopa dywidendy

Kraj